Sections
Title | Starting Page | Number of Pages |
---|
Table of Contents | 2 | 4 |
List of Tables | 4 | 1 |
List of Figures | 5 | 1 |
Avita Medical Ltd, Medical Equipment, Deals By Year, 2010 to YTD 2016 | 5 | 2 |
Avita Medical Ltd, Medical Equipment Deals By Type, 2010 to YTD 2016 | 7 | 1 |
Avita Medical Ltd, Medical Equipment, Deals By Region, 2010 to YTD 2016 | 8 | 1 |
Avita Medical Ltd, Medical Equipment, Deals By Market, 2010 to YTD 2016 | 9 | 1 |
Avita Medical Ltd, Medical Equipment, Deals Summary, 2010 to YTD 2016 | 10 | 1 |
Avita Medical Ltd, Medical Equipment, Deal Details | 11 | 18 |
Asset Purchase | 11 | 1 |
Avita Medical Acquires Intellectual Property From McComb Foundation | 11 | 1 |
Partnerships | 12 | 1 |
Avita Medical Enters into Distribution Agreement with Sinopharm | 12 | 1 |
Avita Medical Enters into Distribution Agreement with Medical Z | 13 | 1 |
Avita Medical Extends Contract with BARDA | 14 | 1 |
Avita Medical Enters into Agreement with University of Huddersfield | 15 | 1 |
Equity Offering | 16 | 1 |
Avita Medical Raises USD6.74 Million in Rights Offering of Shares | 16 | 2 |
Avita Medical Raises USD7.3 Million in Private Placement of Shares | 18 | 2 |
Avita Medical Completes Rights Offering Of Shares For US$3 Million | 20 | 1 |
Avita Medical Completes First Tranche Of Private Placement Of Shares For US$0.5 Million | 21 | 1 |
Avita Medical Completes First Tranche Of Private Placement Of Shares For US$4 Million | 22 | 1 |
Avita Medical Completes Private Placement Of US$9.5 Million | 23 | 2 |
Avita Medical Announces Share Purchase Plan Of US$2.1 Million | 25 | 1 |
Avita Medical Completes Private Placement Of US$0.72 Million | 26 | 1 |
Asset Transactions | 27 | 1 |
Medical Developments Acquires Respiratory Business of Avita Medical for USD1.8 Million | 27 | 2 |
Avita Medical Ltd - Key Competitors | 29 | 1 |
Key Employees | 30 | 1 |
Locations And Subsidiaries | 31 | 1 |
Head Office | 31 | 1 |
Other Locations &Subsidiaries | 31 | 1 |
Recent Developments | 32 | 1 |
Financial Announcements | 32 | 1 |
Jul 29, 2016: Avita Medical Announces Financial Results for Fourth Quarter Fiscal 2016 | 32 | 2 |
Apr 29, 2016: Avita Medical Announces Financial Results for Third Quarter Fiscal 2016 | 34 | 1 |
Feb 26, 2016: Avita Medical Announces Financial Results for First Half Fiscal 2016 | 35 | 3 |
Jan 28, 2016: Avita Medical Announces Financial Results for Second Quarter Fiscal 2016 | 38 | 1 |
Oct 28, 2015: Avita Medical Announces Financial Results and Provides Corporate Update for First Quarter 2016 | 39 | 2 |
Jul 29, 2015: Avita Medical Announces Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year 2015 | 41 | 2 |
Corporate Communications | 43 | 1 |
Jun 20, 2016: Avita Medical Appoints a COO and a VP of Sales and Marketing | 43 | 1 |
Jan 13, 2016: Avita Medical Transforms Board With Three New Appointments | 44 | 2 |
Apr 14, 2015: Avita Medical Appoints Adam Kelliher as Chief Executive Officer | 46 | 1 |
Product News | 47 | 1 |
Mar 15, 2016: Avita Medical Completes Repigmentation Study Enrollment | 47 | 1 |
Mar 08, 2016: Avita Medical Announces Positive Results from Randomized, Multicentre EU Study of ReGenerCell for Treatment of Chronic Venous Leg Ulcers | 48 | 2 |
Mar 02, 2016: Avita Medical Launches Regenerative Product ReGenerCell in Europe | 50 | 1 |
Mar 02, 2016: Avita Medical Launches Regenerative Product ReNovaCell in Europe | 51 | 1 |
Feb 11, 2016: Avita Medical Appoints Distributor for Germany, Switzerland, Austria | 52 | 1 |
Dec 14, 2015: FDA Grants ReCell Expedited Access Pathway Designation | 53 | 1 |
Oct 22, 2015: Avita Medical Announces First Patient Treated in US Military Wound Trial | 54 | 1 |
Oct 13, 2015: Avita Medical Provides Update on ReCell Success in Treating Burn Victims in Taiwan | 55 | 1 |
Oct 04, 2015: Avita Medical Announces U.S. FDA Doubles Patient Numbers Permitted for Compassionate Use of ReCell | 56 | 1 |
Jul 06, 2015: Avita Medical Data Demonstrating ReCell Effectiveness in Skin Repigmentation Published in Journal of the American Academy of Dermatology | 57 | 1 |
Apr 27, 2015: Avita Medical Granted CE Mark for Expanded ReCell | 58 | 1 |
Jan 28, 2015: Avita Medical Announces First Patient Enrollment in US Pivotal Study of ReCell for the Treatment of Burns | 59 | 1 |
Product Approvals | 60 | 1 |
Dec 14, 2015: FDA Grants ReCell Expedited Access Pathway Designation | 60 | 1 |
Oct 04, 2015: Avita Medical Announces U.S. FDA Doubles Patient Numbers Permitted for Compassionate Use of ReCell | 61 | 1 |
Apr 27, 2015: Avita Medical Granted CE Mark for Expanded ReCell | 62 | 1 |
Clinical Trials | 63 | 1 |
Mar 15, 2016: Avita Medical Completes Repigmentation Study Enrollment | 63 | 1 |
Mar 08, 2016: Avita Medical Announces Positive Results from Randomized, Multicentre EU Study of ReGenerCell for Treatment of Chronic Venous Leg Ulcers | 64 | 2 |
Jan 28, 2015: Avita Medical Announces First Patient Enrollment in US Pivotal Study of ReCell for the Treatment of Burns | 66 | 1 |
Other Significant Developments | 67 | 1 |
Sep 28, 2016: Avita Medical Signs Exclusive Distributor Deal in Iran | 67 | 1 |
Jun 07, 2016: Avita Medical Signs Deal for Distribution in Malaysia | 68 | 1 |
Feb 05, 2016: Avita Medical Completes Sale of Respiratory Business for $2.47m | 69 | 1 |
Jan 14, 2016: Avita Medical Appoints Distributors in Japan and South Korea | 70 | 1 |
Nov 04, 2015: Avita Medical Expands Commercial Reach for ReCell in Wound Care Market with the Appointment of Distributors in France and the UK | 71 | 1 |
Sep 29, 2015: Avita Medical Awarded US Government Contract Valued at up to $53.9m USD | 72 | 1 |
Appendix | 73 | 1 |
Methodology | 73 | 1 |
About GlobalData | 73 | 1 |
Contact Us | 73 | 1 |
Disclaimer | 73 | 1 |